These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6203092)
21. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. Lachenauer CS; Baker CJ; Baron MJ; Kasper DL; Gravekamp C; Madoff LC J Infect Dis; 2002 Feb; 185(3):368-74. PubMed ID: 11807719 [TBL] [Abstract][Full Text] [Related]
23. Protective value of gamma globulin preparations against group B streptococcal infections in chick embryos and mice. Vogel LC; Kretschmer RR; Padnos DM; Kelly PD; Gotoff SP Pediatr Res; 1980 Jun; 14(6):788-92. PubMed ID: 6157144 [TBL] [Abstract][Full Text] [Related]
24. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648 [TBL] [Abstract][Full Text] [Related]
26. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children. Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669 [TBL] [Abstract][Full Text] [Related]
27. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice. Gravekamp C; Rosner B; Madoff LC Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787 [TBL] [Abstract][Full Text] [Related]
28. [ELISA for type-specific group B streptococcal antibody and its clinical significance]. Ooe Y; Nishiyama Y; Sugiyama A; Simizu S; Kunishima S; Itou T; Sugiyama M Kansenshogaku Zasshi; 1990 Oct; 64(10):1251-4. PubMed ID: 2258642 [TBL] [Abstract][Full Text] [Related]
29. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329 [TBL] [Abstract][Full Text] [Related]
30. Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib. Boyer KM; Kendall LS; Papierniak CK; Klegerman ME; Gotoff SP Infect Immun; 1984 Sep; 45(3):618-24. PubMed ID: 6381309 [TBL] [Abstract][Full Text] [Related]
31. Surface-localized protein antigens of group B streptococci. Ferrieri P Rev Infect Dis; 1988; 10 Suppl 2():S363-6. PubMed ID: 3055205 [TBL] [Abstract][Full Text] [Related]
32. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. Shigeoka AO; Pincus SH; Rote NS; Hill HR J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154 [TBL] [Abstract][Full Text] [Related]
33. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461 [TBL] [Abstract][Full Text] [Related]
34. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [TBL] [Abstract][Full Text] [Related]
35. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562 [TBL] [Abstract][Full Text] [Related]
36. Estimation of the protective level of human IgG antibody to the type-specific polysaccharide of group B Streptococcus type Ia. Klegerman ME; Boyer KM; Papierniak CK; Gotoff SP J Infect Dis; 1983 Oct; 148(4):648-55. PubMed ID: 6355310 [TBL] [Abstract][Full Text] [Related]
37. Mouse protection assay for group B streptococcus type III. Fleming DO Infect Immun; 1982 Jan; 35(1):240-7. PubMed ID: 6172381 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses. Feldman RG; Ferrante A J Infect Dis; 1990 Oct; 162(4):883-7. PubMed ID: 2205651 [TBL] [Abstract][Full Text] [Related]
39. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera. Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816 [TBL] [Abstract][Full Text] [Related]
40. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]